Europe Kirsten Rat Sarcoma (KRAS) Market is expected to grow with the CAGR of 11.8% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Europe Kirsten Rat Sarcoma (KRAS) Market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Kirsten Rat Sarcoma (KRAS) market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
Thermo Fisher Scientific Inc., is dominating player in Kirsten Rat Sarcoma (KRAS) market. The other key players existing in the market includes F. Hoffmann-La Roche Ltd, Biocartis, Illumina, Inc., Merck KGaA, Abbott, QIAGEN, Agilent Technologies, Inc., among others.
Thermo Fisher Scientific Inc., headquartered in Massachusetts, U.S. was founded in 2006. The company engages in the development, manufacture, marketing and sale of medical devices. The company offers Laboratory Supplies, Laboratory Equipment, Laboratory Instruments, Clinical & Diagnostics, Chromatography & Mass Spectrometry, Cell Culture, Protein and Cell Analysis, Molecular Biology & Nucleic Acid Analysis, Sequence-Specific Nucleic Acid Products. The company has presence in North America, Europe, and Asia-Pacific. The company has various subsidiaries that are Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited1 (New Zealand) among others.
F. Hoffman-La Roche Ltd.
F. Hoffman La Roche Ltd. headquartered in Basel, Switzerland and was founded in year 1886. The company is focused on development of innovative medicines and diagnostics tests that help patients live longer and better lives. The company offers Blood Safety, Clinical Chemistry & Immunochemistry, Companion Diagnostics, Custom Biotech, Diabetes Care, Lab Automation & Software Solution, Molecular Diagnostics, Point of Care, and Tissue Diagnostics. The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa. Genentech (U.S), Chugai Pharmaceutical Co. (Japan), ROCHE HOLDING (UK) LIMITED (UK), Roche (Philippines) Inc. (Philippines), Roche Chile Limitada (Chile) among others are the subsidiaries of the company.
Biocartis is headquartered in Mechelen, Belgium and was founded in 2007. The company is focused to offer rapid & easy molecular diagnostics solutions aimed on fast and accurate treatment decisions for oncology patients across the globe. The company offers products for Infectious Disease, Oncology, and Pharma. The company has wide global presence across Americas, Europe, Asia-Pacific, Middle East and Africa. The company has various subsidiaries such as Biocartis NV (Belgium), Biocartis US Inc. (U.S.) and others.
Global Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2027
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2028
Europe Kirsten Rat Sarcoma (KRAS) Market – Industry Trends and Forecast to 2028